Search

Author/Creator Ritchie, David

11. Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China. Issue 7 (2nd July 2016)

Authors:
Lu, Jin; Hou, Jian; Liu, Kai-Yan; Parmar, Simrit; De La Fuente, Adolfo; Andersson, Börje; Yan, ChenHua; Zhou, Daobin; Tan, Daryl; Ritchie, David; Wu, Deipei; Shpall, Elizabeth; Laport, Ginna G.; Li, JianYong; Hu, Jiong; Zhang, Lian Sheng; Wang, Michael; Malhotra, Pankaj; Jiang, Qian; Qin, Yazhen
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 7(2016:Jul.)
Page Start:
1534
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Australia and New Zealand Transplant and Cellular Therapies COVID‐19 vaccination consensus position statement. Issue 8 (22nd August 2021)

Authors:
Hamad, Nada; Ananda‐Rajah, Michelle; Gilroy, Nicole; MacIntyre, Raina; Gottlieb, David; Ritchie, David; Harrison, Simon; Kennedy, Glen; Watson, Anne M.; Greenwood, Matthew; Doocey, Richard; Perera, Travis; Spencer, Andrew; Wong, Eric; O'Brien, Tracey; Shaw, Peter; Conyers, Rachel; Milliken, Samue...
Journal:
Internal medicine journal
Issue:
Volume 51:Issue 8(2021)
Page Start:
1321
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022)

Authors:
Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ...
Journal:
Lancet
Issue:
Volume 400:Issue 10349(2022)
Page Start:
359
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Bone Marrow Transplant Society of Australia and New Zealand COVID‐19 consensus position statement. Issue 6 (14th June 2020)

Authors:
Hamad, Nada; Gottlieb, David; Ritchie, David; Kennedy, Glen; Watson, Anne M.; Greenwood, Matthew; Doocey, Richard; Perera, Travis; Spencer, Andrew; Wong, Eric; O'Brien, Tracey; Shaw, Peter; Conyers, Rachel; Cole, Theresa; Milliken, Sam; Bardy, Peter; Larsen, Stephen; Lai, Hock; Butler, Andrew; Fr...
Journal:
Internal medicine journal
Issue:
Volume 50:Issue 6(2020)
Page Start:
774
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma. Issue 7 (1st July 2013)

Authors:
Wong Doo, Nicole; Thompson, Philip A.; Prince, H. Miles; Seymour, John F.; Ritchie, David; Stokes, Kerrie; Burbury, Kate; Wolf, Max; Joyce, Trish; Harrison, Simon J.
Journal:
Leukemia & lymphoma
Issue:
Volume 54:Issue 7(2013:Jul.)
Page Start:
1465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma. Issue 7 (July 2013)

Authors:
Wong Doo, Nicole; Thompson, Philip A.; Prince, H. Miles; Seymour, John F.; Ritchie, David; Stokes, Kerrie; Burbury, Kate; Wolf, Max; Joyce, Trish; Harrison, Simon J.
Journal:
Leukemia & lymphoma
Issue:
Volume 54:Issue 7(2013:Jul.)
Page Start:
1465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea. Issue 1 (2nd January 2017)

Authors:
Douglas, Genevieve; Harrison, Claire; Forsyth, Cecily; Bennett, Michael; Stevenson, William; Hounsell, John; Ratnasingam, Sumita; Ritchie, David; Ross, David M.; Grigg, Andrew
Journal:
Leukemia & lymphoma
Issue:
Volume 58:Issue 1(2017)
Page Start:
89
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10325 (12th February 2022)

Authors:
Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abdallah, Nabeel; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Basir; Abdul Rasheed, Althaf; Abdulakeem, Ajibode; Abdul-Kadir, Rezan; Abdullah, Abdullah; Abdulmumeen, Abdu...
Journal:
Lancet
Issue:
Volume 399:Issue 10325(2022)
Page Start:
665
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. Central nervous system multiple myeloma – potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains. (29th May 2013)

Authors:
Lee, Denise; Kalff, Anna; Low, Michael; Gangatharan, Shane; Ho, Prahlad; Bajel, Ashish; Ritchie, David; Grigg, Andrew; Spencer, Andrew
Journal:
British journal of haematology
Issue:
Volume 162:Number 3(2013:Aug.)
Page Start:
371
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗